Last reviewed · How we verify

NCT03754712

Effect of Vitamin D Administration Along With SSRIs in Patients With Major Depressive Disorder

Status unknown NA Last updated 28 November 2018
What this trial tests

NA trial testing Vitamin D3 in MDD in 90 participants. Status unknown.

Timeline
10 March 2018
Primary endpoint
10 January 2019
28 February 2019

Quick facts

Lead sponsorBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment90
Start date10 March 2018
Primary completion10 January 2019
Estimated completion28 February 2019
Sites1 location across Bangladesh

Drugs / interventions tested

Conditions studied

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Who can join

Adults 18 to 60, any sex, with MDD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Several studies suggested low serum levels of vitamin D have been associated with depression. So, the present study is designed to investigate the effect of vitamin D administration along with SSRIs in patients with MDD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vitamin D3

Trials testing the same drug.

Other recruiting trials for MDD

Currently open trials in the same condition.

Other Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03754712.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing